Canadian Prescription Drug Importation
Download Canadian Prescription Drug Importation full books in PDF, epub, and Kindle. Read online free Canadian Prescription Drug Importation ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads.
Author |
: National Academies of Sciences, Engineering, and Medicine |
Publisher |
: National Academies Press |
Total Pages |
: 235 |
Release |
: 2018-03-01 |
ISBN-10 |
: 9780309468084 |
ISBN-13 |
: 0309468086 |
Rating |
: 4/5 (84 Downloads) |
Synopsis Making Medicines Affordable by : National Academies of Sciences, Engineering, and Medicine
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Author |
: United States. Congress. House. Committee on Government Reform. Subcommittee on Human Rights and Wellness |
Publisher |
: |
Total Pages |
: 150 |
Release |
: 2003 |
ISBN-10 |
: PURD:32754077080202 |
ISBN-13 |
: |
Rating |
: 4/5 (02 Downloads) |
Synopsis Canadian Prescription Drug Importation by : United States. Congress. House. Committee on Government Reform. Subcommittee on Human Rights and Wellness
Author |
: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health |
Publisher |
: |
Total Pages |
: 118 |
Release |
: 2002 |
ISBN-10 |
: STANFORD:36105050287221 |
ISBN-13 |
: |
Rating |
: 4/5 (21 Downloads) |
Synopsis Examining Prescription Drug Importation by : United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health
Author |
: United States. Congress. Senate. Committee on Commerce, Science, and Transportation |
Publisher |
: |
Total Pages |
: 68 |
Release |
: 2012 |
ISBN-10 |
: MINN:31951D036191103 |
ISBN-13 |
: |
Rating |
: 4/5 (03 Downloads) |
Synopsis Options for Safe and Effective Prescription Drug Importation by : United States. Congress. Senate. Committee on Commerce, Science, and Transportation
Author |
: United States. Congress. Senate. Special Committee on Aging |
Publisher |
: |
Total Pages |
: 80 |
Release |
: 2005 |
ISBN-10 |
: PURD:32754078645243 |
ISBN-13 |
: |
Rating |
: 4/5 (43 Downloads) |
Synopsis Internet Pharmacy and Drug Importation by : United States. Congress. Senate. Special Committee on Aging
Author |
: Institute of Medicine |
Publisher |
: National Academies Press |
Total Pages |
: 377 |
Release |
: 2013-06-20 |
ISBN-10 |
: 9780309269391 |
ISBN-13 |
: 0309269393 |
Rating |
: 4/5 (91 Downloads) |
Synopsis Countering the Problem of Falsified and Substandard Drugs by : Institute of Medicine
The adulteration and fraudulent manufacture of medicines is an old problem, vastly aggravated by modern manufacturing and trade. In the last decade, impotent antimicrobial drugs have compromised the treatment of many deadly diseases in poor countries. More recently, negligent production at a Massachusetts compounding pharmacy sickened hundreds of Americans. While the national drugs regulatory authority (hereafter, the regulatory authority) is responsible for the safety of a country's drug supply, no single country can entirely guarantee this today. The once common use of the term counterfeit to describe any drug that is not what it claims to be is at the heart of the argument. In a narrow, legal sense a counterfeit drug is one that infringes on a registered trademark. The lay meaning is much broader, including any drug made with intentional deceit. Some generic drug companies and civil society groups object to calling bad medicines counterfeit, seeing it as the deliberate conflation of public health and intellectual property concerns. Countering the Problem of Falsified and Substandard Drugs accepts the narrow meaning of counterfeit, and, because the nuances of trademark infringement must be dealt with by courts, case by case, the report does not discuss the problem of counterfeit medicines.
Author |
: Susan C. Boyd |
Publisher |
: |
Total Pages |
: 160 |
Release |
: 2016 |
ISBN-10 |
: 1552668509 |
ISBN-13 |
: 9781552668504 |
Rating |
: 4/5 (09 Downloads) |
Synopsis More Harm Than Good by : Susan C. Boyd
In an era when the "war on drugs" has resulted in increasingly militarized responses from police, harsh prison sentences and overcrowded prisons, a re-examination of drug policy is sorely needed. Are prohibitive policies actually effective? In what ways do prohibitive policies affect health care, education, housing and poverty? More Harm Than Good examines the past and current state of Canadian drug policy, especially as it evolved under the Conservative government, and raises key questions about the effects of Canada's increased involvement in and commitment to the war on drugs. The analysis in this book is shaped by critical sociology and feminist perspectives and incorporates insights not only from treatment and service workers on the front lines but also from those who live with the consequences of drug policy on a daily basis: people who use criminalized drugs. The authors propose realistic alternatives to today's failed policy approach and challenge citizens and governments at all levels in Canada to chart a new course in addressing drug-related issues.
Author |
: Shayerah Ilias |
Publisher |
: Nova Publishers |
Total Pages |
: 84 |
Release |
: 2008 |
ISBN-10 |
: 1604565624 |
ISBN-13 |
: 9781604565621 |
Rating |
: 4/5 (24 Downloads) |
Synopsis Intellectual Property Rights and International Trade by : Shayerah Ilias
Introduction -- Intellectual property rights basics -- Global intellectual property holdings -- Contribution of intellectual property to U.S. economy -- The organized structure of IPR protection -- U.S. trade law -- Issues for Congress.
Author |
: |
Publisher |
: |
Total Pages |
: 40 |
Release |
: 1926 |
ISBN-10 |
: UCAL:B2708227 |
ISBN-13 |
: |
Rating |
: 4/5 (27 Downloads) |
Synopsis Concerning wholesale by :
Author |
: Rosemary Gibson |
Publisher |
: Prometheus Books |
Total Pages |
: 306 |
Release |
: 2018 |
ISBN-10 |
: 9781633883819 |
ISBN-13 |
: 1633883817 |
Rating |
: 4/5 (19 Downloads) |
Synopsis China Rx by : Rosemary Gibson
Millions of Americans are taking prescription drugs made in China and don't know it-- and pharmaceutical companies are not eager to tell them. This probing book examines the implications for the quality and availability of vital medicines for consumers. Several decades ago, penicillin, vitamin C, and many other prescription and over-the-counter products were manufactured in the United States. But with the rise of globalization, antibiotics, antidepressants, birth control pills, blood pressure medicines, cancer drugs, among many others are made in China and sold in the United States. China's biggest impact on the US drug supply is making essential ingredients for thousands of medicines found in American homes and used in hospital intensive care units and operating rooms. The authors convincingly argue that there are at least two major problems with this scenario. First, it is inherently risky for the United States to become dependent on any one country as a source for vital medicines, especially given the uncertainties of geopolitics. For example, if an altercation in the South China Sea causes military personnel to be wounded, doctors may rely upon medicines with essential ingredients made by the adversary. Second, lapses in safety standards and quality control in Chinese manufacturing are a risk. Citing the concerns of FDA officials and insiders within the pharmaceutical industry, the authors document incidents of illness and death caused by contaminated medications that prompted reform. This is a disturbing, well-researched book and a wake-up call for improving the current system of drug supply and manufacturing.